Calcium As a Cardiovascular Toxin in CKD-MBD

Overview

Journal Bone

Specialties Endocrinology
Orthopedics

Date 2016 Sep 1

PMID 27576942

Citations 20

Authors

Sharon M Moe

Affiliations

Soon will be listed here.

Abstract

Disordered calcium balance and homeostasis are common in patients with chronic kidney disease. Such alterations are commonly associated with abnormal bone remodeling, directly and indirectly. Similarly, positive calcium balance may also be a factor in the pathogenesis of extra skeletal soft tissue and arterial calcification. Calcium may directly affect cardiac structure and function through direct effects to alter cell signaling due to abnormal intracellular calcium homeostasis 2) extra-skeletal deposition of calcium and phosphate in the myocardium and small cardiac arterioles, 3) inducing cardiomyocyte hypertrophy through calcium and hormone activation of NFAT signaling mechanisms, and 4) increased aorta calcification resulting in chronic increased afterload leading to hypertrophy. Similarly, calcium may alter vascular smooth muscle cell function and affect cell signaling which may predispose to a proliferative phenotype important in arteriosclerosis and arterial calcification. Thus, disorders of calcium balance and homeostasis due to CKD-MBD may play a role in the high cardiovascular burden observed in patients with CKD.

Citing Articles

Ten tips on how to assess bone health in patients with chronic kidney disease.

Jorgensen H, Lloret M, Lalayiannis A, Shroff R, Evenepoel P Clin Kidney J. 2024; 17(5):sfae093.

PMID: 38817914 PMC: 11137676. DOI: 10.1093/ckj/sfae093.

Role of Nutrients in Pediatric Non-Dialysis Chronic Kidney Disease: From Pathogenesis to Correct Supplementation.

Padoan F, Guarnaroli M, Brugnara M, Piacentini G, Pietrobelli A, Pecoraro L Biomedicines. 2024; 12(4).

PMID: 38672265 PMC: 11048674. DOI: 10.3390/biomedicines12040911.

Gut Microbiota's Oxalate-Degrading Activity and Its Implications on Cardiovascular Health in Patients with Kidney Failure: A Pilot Prospective Study.

Stepanova N, Tolstanova G, Aleksandrova I, Korol L, Dovbynchuk T, Driianska V Medicina (Kaunas). 2023; 59(12).

PMID: 38138292 PMC: 10744410. DOI: 10.3390/medicina59122189.

Long-term effects of hypercalcemia in kidney transplant recipients with persistent hyperparathyroidism.

Ramirez-Sandoval J, Marino L, Cojuc-Konigsberg G, Reul-Linares E, Pichardo-Cabrera N, Cruz C J Nephrol. 2023; 37(6):1497-1507.

PMID: 38032457 DOI: 10.1007/s40620-023-01815-5.

Regulatory effects of nutritional and metabolic disorders on vascular calcification in chronic kidney disease: a narrative review.

Xiong Y, Yu Y, Su B Ann Transl Med. 2023; 11(11):384.

PMID: 37970595 PMC: 10632569. DOI: 10.21037/atm-22-5358.

References

Naruse Y, Tada H, Sekiguchi Y, Machino T, Ozawa M, Yamasaki H . Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up. Heart Rhythm. 2010; 8(3):335-41. DOI: 10.1016/j.hrthm.2010.10.047. View

Zhao Y, Chen N, Shirazi J, Shen C, Lin S, Fishbein M . Subcutaneous nerve activity and mechanisms of sudden death in a rat model of chronic kidney disease. Heart Rhythm. 2016; 13(5):1105-1112. PMC: 4851901. DOI: 10.1016/j.hrthm.2015.12.040. View

Wang Z, Wang D, Teg Pipes G, Olson E . Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci U S A. 2003; 100(12):7129-34. PMC: 165841. DOI: 10.1073/pnas.1232341100. View

Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A . Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant. 2010; 26(6):1948-55. PMC: 3107766. DOI: 10.1093/ndt/gfq219. View

Allen M, Chen N, Gattone 2nd V, Chen X, Carr A, Leblanc P . Skeletal effects of zoledronic acid in an animal model of chronic kidney disease. Osteoporos Int. 2012; 24(4):1471-81. PMC: 4063946. DOI: 10.1007/s00198-012-2103-x. View

Goldenberg I, Moss A, McNitt S, Zareba W, Andrews M, Hall W . Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol. 2006; 98(4):485-90. DOI: 10.1016/j.amjcard.2006.03.025. View

Wang L, Wang C, Lin Y, Xi Y, Zhang W, Zhao Y . Involvement of calcium-sensing receptor in cardiac hypertrophy-induced by angiotensinII through calcineurin pathway in cultured neonatal rat cardiomyocytes. Biochem Biophys Res Commun. 2008; 369(2):584-9. DOI: 10.1016/j.bbrc.2008.02.053. View

Hill J, Zalos G, Halcox J, Schenke W, Waclawiw M, Quyyumi A . Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003; 348(7):593-600. DOI: 10.1056/NEJMoa022287. View

Block G, Klassen P, Lazarus J, Ofsthun N, Lowrie E, Chertow G . Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15(8):2208-18. DOI: 10.1097/01.ASN.0000133041.27682.A2. View

10.

Amann K, Kronenberg G, Gehlen F, Wessels S, Orth S, Munter K . Cardiac remodelling in experimental renal failure--an immunohistochemical study. Nephrol Dial Transplant. 1998; 13(8):1958-66. DOI: 10.1093/ndt/13.8.1958. View

11.

Rivara M, Ravel V, Kalantar-Zadeh K, Streja E, Lau W, Nissenson A . Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis. J Am Soc Nephrol. 2015; 26(7):1671-81. PMC: 4483586. DOI: 10.1681/ASN.2014050472. View

12.

Goldsmith D, Covic A, Venning M, Ackrill P . Blood pressure reduction after parathyroidectomy for secondary hyperparathyroidism: further evidence implicating calcium homeostasis in blood pressure regulation. Am J Kidney Dis. 1996; 27(6):819-25. DOI: 10.1016/s0272-6386(96)90519-3. View

13.

Herzog C, Asinger R, Berger A, Charytan D, Diez J, Hart R . Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011; 80(6):572-86. DOI: 10.1038/ki.2011.223. View

14.

Berra-Romani R, Mazzocco-Spezzia A, Pulina M, Golovina V . Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am J Physiol Cell Physiol. 2008; 295(3):C779-90. PMC: 2544451. DOI: 10.1152/ajpcell.00173.2008. View

15.

Block G, Levin N, Port F . Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998; 31(4):607-17. DOI: 10.1053/ajkd.1998.v31.pm9531176. View

16.

Cheung A, Sarnak M, Yan G, Dwyer J, Heyka R, Rocco M . Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000; 58(1):353-62. DOI: 10.1046/j.1523-1755.2000.00173.x. View

17.

Bogin E, Massry S, Harary I . Effect of parathyroid hormone on rat heart cells. J Clin Invest. 1981; 67(4):1215-27. PMC: 370684. DOI: 10.1172/jci110137. View

18.

Chen N, Kiattisunthorn K, ONeill K, Chen X, Moorthi R, Gattone 2nd V . Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS One. 2013; 8(5):e64558. PMC: 3661525. DOI: 10.1371/journal.pone.0064558. View

19.

Hsueh C, Chen N, Lin S, Chen P, Gattone 2nd V, Allen M . Pathogenesis of arrhythmias in a model of CKD. J Am Soc Nephrol. 2014; 25(12):2812-21. PMC: 4243359. DOI: 10.1681/ASN.2013121343. View

20.

Merx M, Schafer C, Westenfeld R, Brandenburg V, Hidajat S, Weber C . Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice. J Am Soc Nephrol. 2005; 16(11):3357-64. DOI: 10.1681/ASN.2005040365. View